Vitamin K Shots

Print

Link copied

Aluminum adjuvants in vaccines and the newborn vitamin K shot are also significant sources of early exposure. The package insert for Pfizer’s vitamin K formulation warns that the product “contains aluminum that may be toxic,” and it also notes that “premature neonates are particularly at risk,” yet it is standard practice to administer vitamin K shots to preterm infants. Young children go on to receive  multiple aluminum-containing vaccines in their first three years, and more as adolescents. A two-month-old infant may receive up to 1,225 micrograms of aluminum from the vaccines administered at a single well-baby visit and a cumulative 4,925 micrograms by 18 months of age. Regulators have never properly assessed these astronomical levels of aluminum for safety. Co-exposure to aluminum and mercury (still present in influenza vaccines) makes matters synergistically worse.

Institutional Inertia: Is Enough Being Done to Protect Children from Aluminum Toxicity?

Infants in their first year of life are particularly susceptible to aluminum bioaccumulation, raising concerns about the high levels of absorbable aluminum reported in infant formula and in the parenteral (intravenous) nutrition solutions given to premature babies. Suggesting that these reports represent the “tip of an iceberg,” one group of researchers cautions that not only does aluminum constitute a “significant component of newborns’ exposure to xenobiotics and contaminants,” but the consequences of aluminum overload in the perinatal period can have pathological consequences that persist into adulthood.

Vitamin K Shot Warning:

Pfizer Hospira Vitamin K Product Insert